计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
rp174305-500μg |
500μg |
期货 ![]() |
| |
rp174305-1mg |
1mg |
期货 ![]() |
|
产品名称 | IL-33, 白细胞介素-33 受体激动剂 |
---|---|
别名 | IL-1F11 |
英文别名 | IL-1F11 |
规格或纯度 | Moligand™ |
作用类型 | 激动剂 |
作用机制 | 白细胞介素-33 受体激动剂 |
CAS编号和信息 | rp174305 |
---|
1. Hsu CL, Neilsen CV, Bryce PJ. (2010) IL-33 is produced by mast cells and regulates IgE-dependent inflammation.. PLoS ONE, 5 (8): (e11944). [PMID:20689814] [10.1021/op500134e] |
2. Lefrançais E, Cayrol C. (2012) Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members.. Eur Cytokine Netw, 23 (4): (120-7). [PMID:23306193] [10.1021/op500134e] |
3. Cayrol C, Girard JP. (2014) IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy.. Curr Opin Immunol, 31 (13): (31-7). [PMID:25278425] [10.1021/op500134e] |
4. Bandara G, Beaven MA, Olivera A, Gilfillan AM, Metcalfe DD. (2015) Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.. Eur J Immunol, 45 (11): (3034-44). [PMID:26256265] [10.1021/op500134e] |
5. Hung LY, Tanaka Y, Herbine K, Pastore C, Singh B, Ferguson A, Vora N, Douglas B, Zullo K, Behrens EM et al.. (2020) Cellular context of IL-33 expression dictates impact on anti-helminth immunity.. Sci Immunol, 5 (53): (1755-70). [PMID:33188058] [10.1021/op500134e] |
6. Chen YL, Gutowska-Owsiak D, Hardman CS, Westmoreland M, MacKenzie T, Cifuentes L, Waithe D, Lloyd-Lavery A, Marquette A, Londei M et al.. (2019) Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis.. Sci Transl Med, 11 (515): (1755-70). [PMID:31645451] [10.1021/op500134e] |